Ipca Laboratories fell 2.49% to Rs 684 at 13:40 IST on BSE, with the stock declining on profit booking after gaining 13.8% in prior seven trading days.
Meanwhile, the S&P BSE Sensex was down 107.55 points or 0.37% at 29,212.71
On BSE, so far 66,182 shares were traded in the counter as against average daily volume of 42,712 shares in the past one quarter.
The stock hit a high of Rs 714 and a low of Rs 683.15 so far during the day. The stock had hit a record high of Rs 906.90 on 28 February 2014. The stock had hit a 52-week low of Rs 591.25 on 9 February 2015.
The stock had underperformed the market over the past one month till 18 February 2015, falling 1.55% compared with 4.26% rise in the Sensex. The scrip had also underperformed the market in past one quarter, rising 4.04% as against Sensex's 4.11% rise.
The mid-cap company has equity capital of Rs 25.24 crore. Face value per share is Rs 2.
Shares of Ipca Laboratories were on a roll recently, gaining 13.8% in seven trading days to settle at Rs 701.50 on 18 February 2015 from a recent low of Rs 616.40 on 6 February 2015.
Ipca Laboratories' net profit fell 70.1% to Rs 41.53 crore on 10.7% decline in net sales to Rs 734.13 crore in Q3 December 2014 over Q3 December 2013.
Ipca Laboratories is vertically integrated and produces finished dosage forms and active pharmaceuticals ingredients.
Powered by Capital Market - Live News
